Using a relatively stringent analytic approach, we found 31,457 PR-binding sites in breast cancer cells and 7,034 in leiomyoma cells, with 1,035 PR-binding sites that overlapped between the two cell types. The gene discussed is PGR; the disease is leiomyoma.